Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Short-term Investments (2022 - 2025)

CervoMed (CRVO) has disclosed Short-term Investments for 4 consecutive years, with $12.6 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 57.79% to $12.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.6 million through Dec 2025, down 57.79% year-over-year, with the annual reading at $12.6 million for FY2025, 57.79% down from the prior year.
  • Short-term Investments hit $12.6 million in Q4 2025 for CervoMed, down from $17.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $38.9 million in Q3 2024 to a low of $3.0 million in Q1 2023.
  • Historically, Short-term Investments has averaged $22.0 million across 4 years, with a median of $22.6 million in 2022.
  • Biggest five-year swings in Short-term Investments: tumbled 86.81% in 2023 and later dropped 28.14% in 2025.
  • Year by year, Short-term Investments stood at $12.4 million in 2022, then tumbled by 75.89% to $3.0 million in 2023, then surged by 900.16% to $29.9 million in 2024, then plummeted by 57.79% to $12.6 million in 2025.
  • Business Quant data shows Short-term Investments for CRVO at $12.6 million in Q4 2025, $17.9 million in Q3 2025, and $25.2 million in Q2 2025.